Evaluation of the preference, satisfaction and correct use of Breezhaler® and Respimat® inhalers in patients with chronic obstructive pulmonary disease

Evaluation of the preference, satisfaction and correct use of Breezhaler® and Respimat® inhalers in patients with chronic obstructive pulmonary disease – INHALATOR study

Published:2018-11 Issue: Volume:144 Page:61-67
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Oliveira Maria Vera Cruz de,Pizzichini Emilio,da Costa Claudia Henrique,Fritscher Carlos Cezar^ORCID,Vianna Elcio Oliveira,Teixeira Paulo José Zimermann,Stirbulov Roberto,Rabahi Marcelo Fouad,Pinho Nadine Cordeiro de

Funder

Novartis Biociencias S.A., Brazil

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference30 articles.

1. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat® Soft MistTM inhaler;Hodder;Int. J. Chronic Obstr. Pulm. Dis.,2009

2. Managing comorbidities in COPD;Hillas;Int. J. Chronic Obstr. Pulm. Dis.,2015

3. Chronic obstructive pulmonary disease;Vijayan;Indian J. Med. Res.,2013

4. Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA;Cohen;Int. J. Chronic Obstr. Pulm. Dis.,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and Factors Affecting Appropriate Inhaler Use in Elderly Patients with Chronic Obstructive Pulmonary Disease: A Prospective Study;Journal of Clinical Medicine;2023-06-30

2. Inhaler use in chronic obstructive pulmonary disease patients: a meta-analysis^†;Frontiers of Nursing;2022-12-01

3. Tỉ lệ sử dụng đúng cách dụng cụ hít và các yếu tố liên quan trên người bệnh nội trú mắc bệnh phổi tắc nghẽn mạn tính;Journal of Clinical Medicine- Hue Central Hospital;2022-05-31

4. The history, current state and perspectives of aerosol therapy;Acta Pharmaceutica;2021-12-30

5. Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma;Expert Review of Respiratory Medicine;2021-12-22